A public health perspective on research ethics

Journal of Medical Ethics

Volumn 32, Issue 12, 2006, Pages 729-733

  Buchanan, D R ^a   Miller, F G ^b  

^a UNIVERSITY OF MASSACHUSETTS   (United States)

^b NATIONAL INSTITUTES OF HEALTH   (United States)

Author keywords

[No Author keywords available]

Indexed keywords

ARTICLE; BIOETHICS; CLINICAL EFFECTIVENESS; HEALTH PROMOTION; MEDICAL CARE; MEDICAL ETHICS; MEDICAL RESEARCH; MORALITY; PHYSICIAN; PRACTICE GUIDELINE; PUBLIC HEALTH SERVICE; RESEARCH ETHICS; RESEARCH SUBJECT; RISK BENEFIT ANALYSIS; SOCIAL PSYCHOLOGY;

BIOETHICAL ISSUES; CODES OF ETHICS; ETHICS, RESEARCH; HUMANS; MORAL OBLIGATIONS; PUBLIC HEALTH;

EID: 33845787936     PISSN: 03066800     EISSN: None     Source Type: Journal    
DOI: 10.1136/jme.2006.015891     Document Type: Article

References (31)

1. Beauchamp T, Childress J. Principles of biomedical ethics, 5th edn. New York: Oxford University Press, 2001.
2. Veatch R. Disrupted dialogue: medical ethics and the collapse of physician-humanist communication. New York: Oxford University Press, 2005.
3. Childress JR, Faden R, Gaare L, et al. Public health ethics: mapping the terrain. J Law Med Ethics 2002;30:170-8.
4. O'Neill O. Public health or clinical ethics: thinking beyond borders. Ethics Int Affairs 2002;16:35-45.
5. Kass N. An ethics framework for public health. Am J Public Health 2001;91:1776-82.
6. Emanuel E, Wendler D, Grady C. What makes clinical research ethical? JAMA 2000;283:2701-11.
7. McCarthy C. The evolving story of justice in Federal Research Policy. In: Kahn J, Mostroianni A, Sugarman J, eds. Beyond consent. seeking justice in research. New York: Oxford University Press, 1998:11-31.
8. Powers M. Theories of justice in the context of research. In: Kahn J, Mostroicinni A, Sugarman J, eds. Beyond consent. seeking justice in research. New York: Oxford University Press, 1998:147-65.
9. National Commission for the Protection of Human Subjects of Biomedical and Behavioral Research. The Belmont Report: ethical principles and guidelines for the protection of human subjects of research, Federal Register Document 79-12065. Washington, DC: Department of Health and Human Welfare, US Government Printing Office, 1979.
10. Dresser R. Wanted: single, white male for medical research. Hastings Cent Rep 1992;22:24-9.
11. Kahn J, Mastroianni A, Sugarman J. Changing claims about justice in research: an introduction and overview. In: Kahn J, Mastroiainni A, Sugarman J, eds. Beyond consent. seeking justice in research. New York: Oxford University Press, 1998:1-25.
12. Weijer C, Crouch, RA. Why should we include women and minorities in randomized controlled trials? J Clin Ethics 1999;10:100-6.
13. Fried C. Medical experimentation: personal integrity and social policy. Amsterdam: North-Holland Publishing Company, 1974.
14. Marquis D. Leaving therapy to chance. Hastings Cent Rep 1983;13:40-7.
15. O'Brien P, Fleming T. A multiple testing procedure for clinical trials. Biometrics 1979;35:549-56.
16. Jennison C, Turnbull B. Group sequential methods with applications to clinical trials. Boca Raton: Chapman and Hall, 2000.
17. Buchanan D, Miller FG. Principles of early stopping of randomized trials for efficacy: a critique of equipoise and an alternative ethical framework. Kennedy Inst Ethics J 2005;15:163-80.
18. Montori VM, Devereaux PJ, Adhikari NK, et al. Randomized trials stopped early for benefit: a systematic review. JAMA 2005;294:2203-9.
19. Horton R. Vioxx, the implosion of Merck, and aftershocks at the FDA. Lancet 2004;364:1995-6.
20. Writing Group for the Women's Health Initiative Investigators. Risks and benefits of estrogen plus progestin in healthy postmenopausal women: principal results rom the women's health initiative randomized controlled trial. JAMA 2002;288:321-33.
21. Pocock SJ. When (not) to stop a clinical trial. JAMA 2005;294:2228-30.
22. Gifford F. Community-equipoise and the ethics of randomized clinical trials. Bioethics 1995;9:127-48.
23. Angell M. The ethics of clinical research in the third world. N Engl J Med 1997;337:847-9.
24. Angell M. Investigators' responsibilities for human subjects in developing countries. N Engl J Med 2000;342:967-9.
25. Spriggs M. Canaries in the mines: children, risk, non-therapeutic research, and justice. J Med Ethics 2004;30:176-81.
26. Farmer P, Campos NG. New malaise: bioethics and human rights in the global era. J Law Med Ethics 2004;32:243-51.
27. Pollak J. The lead-based paint abatement repair and maintenance study in Baltimore: historic framework and study design. J Health Care Low Policy 2002;6:89-108.
28. Buchanan D, Miller FG. Justice and fairness in the Kennedy Krieger Institute Lead Paint Study: the ethical justification for public health research on less expensive yet less effective interventions. Am J Public Health 2006;96:15-22.
29. Pinder L. Commentary on the Kennedy Krieger Institute Lead Paint Repair and Maintenance Study. Neurotoxicol Teratol 2002;24:477-9.
30. Needleman H. What is not found in the spreadsheets? Neurotoxicol Teratol 2002;24:459-61.
31. Emanuel EJ, Wendler D, Killen J, et al. What makes clinical research in developing countries ethical? The benchmarks of ethical research. J infect Dis 2004;189:930-7.